Jul. 27, 2026
Programmable mRNA 3′UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer Journal: Nature Author: Furong Huang et al., USA A programmable RNA engineering platform restores immune recognition in prostate cancer, helping overcome tumor immune evasion and improve responses to immunotherapy. Click to see the full article AI-redesigned starting points and outcomes enhance protein […]